Real-world survival outcomes associated with use of pertuzumab and trastuzumab emtansine (T-DM1) for HER2-positive (HER2+) metastatic breast cancer (MBC) in Brazilian private healthcare setting
Dienstmann, Rodrigo, Cruz, Heloisa, Coelho Gonçalves, Aline, Andrade, Diocesio Alves Pinto de, Liedke, Pedro Emanuel Rubini, Costa, Rafael Brant, Dantas Loures da Costa, Mario Alberto, Boukai, Alexandre, Paes, Flavia Rocha, Landeiro, Luciana G., Gimenes, Daniel Luiz, Magalhaes, Maria Cristina Figueroa, Resende, Cristiano Augusto Andrade de, Reinert, Tomas, Aguiar Junior, Pedro N., Paes, Rafael, Costa e Silva, Matheus, Ferrari, Bruno Lemos, Mano, Max S.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article